Long-term therapeutic efficacy and toxicity of recombinant interferon- alpha 2a in polycythaemia vera

European Journal of Haematology

Volumn 60, Issue 5, 1998, Pages 273-277

  Foa, P ^a,b   Massaro, P ^a   Caldiera, S ^a   LaTargia, M L ^a   Iurlo, A ^a   Clerici, C ^a   Fornier, M ^a   Bertoni, F ^a   Maiolo, A T ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE   (Italy)

Author keywords

Polycythaemia vera; Recombinant interferon alpha

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOCRIT; HUMAN; INFLUENZA; MALE; MUSCLE WEAKNESS; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PRURITUS; TREATMENT OUTCOME;

EID: 0031865127     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01039.x     Document Type: Article

References (19)

1. ADAMSON JW, FIALKOW PJ, MURPHY S, PREEHAL JF, STEINMANN L. Polycythemia vera: stem cell and probable clonal origin of the disease. N Engl J Med 1976: 295: 913-919.
2. BERK PD, GOLDBERG JD, DONOVAN PB, FRUCHTMAN SM, BERLIN NI, WASSERMANN LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986: 23: 132-143.
3. 32P between 1969 and 1981. Semin Hematol 1997: 34: 6-16.
4. KAPLAN ME, MACK K, GOLDBERG JD, DONOVAN PB, BERK PD, WASSERMANN LR. Long term management of polycythemia vera with hydroxyurea. Semin Hematol 1986: 23: 167-171.
5. WEINFELD A, SWOLIN B, WESTIN J. Acute leukemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemo-genicity with therapeutic implications. Eur J Haematol 1994: 52: 134-139.
6. FRUCHTMAN SM, MACK K, KAPLAN ME, PETERSON P, BERK PD, WASSERMANN LR. From efficacy to safety: a Polycythemia Vera Study Group Report on hydroxyurea in patients with polycythemia vera. Semin Hematol 1997: 34: 17-23.
7. TALPAZ M, KANTARJIAN HM, MCCREDIE K, TRUJILLO JM, KEATING MJ, GUTTERMANN JU. Hematological remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 1986: 314: 1065-1069.
8. GILES FJ, GRAY AG, BROSOVIC M, et al. Alpha-interferon therapy for essential thrombocythemia. Lancet 1998: ii: 70-72.
9. BAROSI G, LIBERTATO LN, COSTA A, ASCARI E. Cytoreductive effects of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut 1989: 58: 271-274.
10. CIMINO R, RAMETTA V, MATERA C, MELE G, METTIVIER V, FERRARA F. Recombinant Interferon alpha 2-b in the treatment of polycythemia vera. Am J Hematol 1993: 44: 155-157.
11. FOA P, MASSARO P, RIBERA S, IURLO A, MEZZANOTTE C, GIANDALIA D, MAIOLO AT. Role of interferon alpha-2a in the treatment of polycythemia vera. Am J Hematol 1995: 48: 55-57.
12. PAPINESCHI F, BUCALOSSI A, CAPOCHIANI E, et al. Recombinat alpha 2a interferon and polycythemia vera: clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy. Eur J Haematol 1994: 53: 213-217.
13. SACCHI S, LEONI P, LIBERATI M, et al. A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. Ann Haematol 1994: 68: 247-250.
14. SILVER RT. Interferon-alpha 2b: a new treatment for polycythemia vera. Ann Intern Med 1993: 119: 1091-1092.
15. TAYLOR PC, DOLAN J, NG JP, PAUL B, COLLIN R, REILLY JT. Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythemia vera: a study of 17 patients and an analysis of published data. Br J Haematol 1996: 92: 55-59.
16. TURRI D, MITRA ME, DI TRAPANI R, LIPANI MG, PERRICONE R, CAJOZZO A. Interferon in polycythemia vera and essential thrombocythemia. Haematologica 1991: 76: 75-77.
17. MULLER EW, DE WOLF JTHM, EGGER R, et al. Long-term treatment with interferon-alpha2b for severe pruritus in patients with polycythemia vera. Br J Haematol 1995: 89: 313-318.
18. SALEM HH, VAN DER WEYDEN MB, YOUNG IF, WILEY JS. Pruritus and sever iron deficiency in polycythemia. Br Med J 1982: 285: 91-92.
19. SILVER RT. Interferon alfa: effects of long-term treatment for polycythemia vera. Semin Hematol 1997: 40-50.